Several potential compounds with acceptable characteristics have been identified, such as benzoxazole 18F-BF227, which shows a high affinity for amyloid and low affinity for SNCA in postmortem brain tissues from MSA patients [75,76]. This evidence concerns the gene SNCA and multiple system atrophy.